Temperature controlled pharmaceutical containers are the packaging systems primarily designed to maintain temperature sensitivity and preferred temperatures payloads. These containers are used for providing the packaging for the pharmaceutical products which are highly reactive or sensitive towards the temperature rise.
These containers provide protection, identification, information and containment to product during storage, carriage and until the product is appropriately consumed. The drugs such as insulin or the cancer treatment drugs require constant temperature or control to be maintained for their stability. Through temperature controlled packaging, these drugs can easily transported to particular locations, preventing over any harmful external effects.
Temperature controlled packaging solutions are impeccable for the transport of temperature sensitive products in extreme conditions, over prolonged periods and under the extreme heat conditions. Some of the other major factor driving growth of temperature controlled packaging market includes higher performance, higher efficiency comparison to any other insulating materials, These containers also supports the better temperature maintenance, with the reduced thickness on the sides.
According to study, “Global Pharmaceutical Temperature-controlled Containers Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use” the key companies operating in the global pharmaceutical temperature-controlled containers market are Sonoco Products Company, Sofrigam SA Ltd., Pelican Biothermal LLC, American Aerogel Corporation, Cryopak, ACH Foam Technologies, LLC, Cold Chain Technologies Inc., va-Q-tec AG, Envirotainer Ltd., Inmark Packaging.
Based on type, pharmaceutical temperature-controlled containers market is segmented into active system and passive system. The active temperature-controlled packaging solutions are majorly utilized by allowing the transportation of all variant sizes of the temperature sensitive transportation. The use of these containers includes passive controlled packaging solution arrangement permitting mass delivery at a lesser expense. Based on style, market is segmented into upright style and chest style. Based on temperature range, market is segmented into up to 10°C, 10°C to 20°C and more than 20°C. Based on type of use, market is segmented into single use and reusable. In addition, based on application, market is segmented into vaccines/drugs, reagents, samples (blood, biopsy etc.) and genetic materials.
The pharmaceutical temperature-controlled containers market is driven by increase in focus on reducing wastage of Pharma products followed by the need drug storage due to rapid growth in the prevalence of chronic diseases, rise in focus on new drug development and increase in clinical trials for treatment of chronic diseases. However, lack of logistics facility and lack of skilled workforce may impact the market. Moreover, increase in number of clinical trials in the countries is adding to the key opportunity over the market.
Based on geography, North-American is one of the leading region in the pharmaceutical temperature-controlled containers use owing to the stringent pharmaceutical products safety policies and rise in research & development (R&D) investments. However, European and Asian-Pacific regions are also expected to register high growth rate due to strict regional goods distribution practices and increase in innovation & development of novel packaging solutions over the forecast period. In the forecast period market is expected to remain optimistic based on increase in pharmaceutical spending over the Governments of different countries.
For More Information, click on the link below:-
Ankur Gupta, Head Marketing & Communications